The lower urinary tract is aected by multiple sclerosis in many patients. We screened urologically and neurologically 120 patients with a con®rmed diagnosis of multiple sclerosis. The mean age was 42 years (range 22 to 69 years). Urodynamic investigation as well as neuro-urophysiological investigations were performed in all patients. Renal ultrasound was used to study morphology, and excretory urogram (IVU) was used to assess renal function and the upper urinary tracts in 105 patients. Obstructive symptoms were found more commonly than irritative symptoms. The urinary symptoms were found to be related to disease duration and not to disability status. Urodynamic abnormalities were statistically signi®cantly related to disease duration (X 2 =38.51; P=0.0001), and to the disability status (X 2 =76.70; P=0.0001). Few patients, only 3.3%, had upper urinary tract dilatation. With medical management, hydronephrosis disappeared in all of the patients and did not recur. A combination of oral pharmacological agents and clean intermittent catheterization was used in the majority of the patients.
Introduction
Vesicourethral dysfunction is a common ®nding in patients aicted with multiple sclerosis, the reported incidence being as high as 75%. 1, 2 Fortunately, upper tract complications and renal failure in multiple sclerosis are extremely uncommon. 3, 4 Some studies report that objective lower urinary tract dysfunction can be present without complaints. 5 Several investigators found a poor relationship between the subjective complaints and the objective neurological parameters. Therefore, a neurourological diagnostic evaluation seems to be mandatory both in patients with urological complaints and in those without symptoms. Few authors 6, 7 studied the relationship between urological abnormalities and the severity and state of disability of the other features of multiple sclerosis. The aim of our study was to compare urodynamic behaviour with disease duration, physical examination, and disability status.
Patients and methods
Between January 1992 and October 1995, 120 patients with a con®rmed diagnosis of multiple sclerosis were evaluated. The mean age was 42 years (range 22 to 69 years). Patient evaluation included a detailed neurourological examination including evaluation of anal sphincter tone, bulbocavernosus re¯ex and knee and ankle re¯exes; the disability was established according to the Kurtzke expanded disability status scale. 8 According to this scale, patients are divided into eight groups (Table 1) ; we grouped the patients in four classes (I-IV), including eight groups.
1 ± 8 Patient complaints were classi®ed as irritative, obstructive and urinary incontinence. Urodynamic investigation as well as neuro-urophysiological investigations were performed in all of the patients. Renal ultrasound or excretory urogram (IVP) were used to assess renal function and the upper tracts in 105 patients. Urodynamic examination was performed according to the standards of the International Continence Society. 9 The residual urine was measured by means of catheterization before and after the urodynamic investigation. During cystometry special attention was paid to the ®rst desire to void and the maximum cystometric capacity. A ®rst desire to void of 200 ml or more in combination with a maximum cystometric capacity of 500 ml or more was considered hyposensitive. On the contrary, a ®rst desire to void of 50 ml or less was considered hypersensitive.
The course of the disease was documented in each patient as being exacerbating-remitting and/or chronic-progressive. The intracranial and spinal lesions, documented by means of magnetic resonance imaging (MRI), were evaluated in 105 patients.
For the statistical comparison of two-sample distributions of an (at least) ordinal variable, the Wilcoxon two-sample test was appropriate. If the P value of the statistical test was 50.05 the dierence between the two samples was considered statistically signi®cant.
Results
Gender dierences among the groups regarding the following classi®cation parameters were not statistically signi®cant. The group distributions regarding multiple sclerosis classi®cation parameters of disease duration and disability status are given in Table 1 . Lower urinary tract symptoms were present in all of the patients. Obstructive complaints were found more frequently than irritative complaints in the early (1 ± 48 months) and in late stages (4109 months) of the disease. Table 2 shows that disease duration is related to the clinical symptoms. It also shows that urinary tract symptoms are not related to the disability status score. Urodynamic abnormalities were statistically signi®cantly related to disease duration (X 2 =38.51; P=0.0001) ( Table 3) . Urodynamic abnormalities were also related to the disability status scale (Table 4) . Gender dierences among the groups regarding the aforementioned parameters were not statistically signi®cant. On MRI examination 96 patients out of 105 had intracranial or spinal lesions of various grade. The imaging of the upper tracts showed dilatation in only four patients (3.3%). With medical management, hydronephrosis improved and then disappeared in all of the patients and did not recur. In most patients with a severe disability status score a chronic-progressive course of the disease was observed, while a exacerbating-remitting course was more common in patients with a less severe disability status.
With regard to treatment, which was based upon the dierent urodynamic ®ndings, the interval to follow-up was in¯uenced by the severity of the urodynamic ®ndings. Most patients, 77, were treated with a combination of oral pharmacological agents and clean intermittent catheterization. Behavioural modi®cation, performed on eight patients, included timed voiding and¯uid restriction. In six patients with voiding symptoms refractory to oral pharmacological drugs, or with intolerable systemic side eects, intravesical oxybutynin was used (5 mg oxybutynin tablet dissolved in 30 cc. saline, instilled for 45 minutes by catheter). Six patients reported signi®cant improvement in the voiding symptoms. 
Discussion
The hallmark of multiple sclerosis is a changing neurological behaviour with varying clinical symptoms, usually in a stepwise progression. 10 Disturbances in micturition as well as sexual function are important features of the neurological disorder in patients with multiple sclerosis. In general, the severity of the bladder symptoms parallels the severity of the neurological symptoms, particularly those involving the corticospinal tracts. The aim of therapy is to protect and preserve renal function, and eradicate symptomatic voiding dysfunction and incontinence to provide a normal life-style. In most studies, irritative bladder symptoms were seen more frequently than obstructive symptoms (60% versus 25-33%).
11 ± 13 We found that obstructive symptoms were more prevalent.
Some authors 14 have already reported that multiple sclerosis patients with a short disease duration can suer from serious voiding problems, but usually micturition problems appear related to the disability status. 7, 11, 14 Our ®ndings con®rm a statistically signi®cant positive relationship between disease duration and micturition complaints 7 ( Table 2) . On the other hand, we did not ®nd a signi®cant relation between lower urinary tract symptoms and the disability status, when considering four classes of patients, each including two groups, according to the Kurtzke disability status scale (Table 2) . Urodynamic abnormalities were signi®cantly related to both disease duration and the disability status (Tables 3 ± 4 ). An important ®nding of some studies 5 is the sizable percentage of urodynamic abnormalities in urologically silent multiple sclerosis patients. Half of the patients who did not have urinary complaints on questioning had objective urodynamic abnormalities. 5 This con®rms once more that lower urinary tract symptoms do not correlate with the underlying pathophysiology of bladder dysfunction, and suggests that urodynamic evaluation is necessary. Some authors 15 suggest that the urological evaluation of this disease should be limited to physical examination and post-void residual urine measurement; we agree with other investigators 10, 16 that urodynamic evaluation of bladder function is critical to establish a treatment program.
Drug treatment may require adjustment to ®nd an eective agent, without serious side eects. Intravesical oxybutynin proved to be eective in six out of eight patients (75%), and systemic side eects were absent.
Detrusor hypoactivity was the prevalent urodynamic abnormality we observed, followed by detrusor hyperactivity; a combination of both ®ndings was noted in almost a quarter of all patients. This explains why clean intermittent catheterization, usually in combination with oral or intravesical anticholinergic drugs, was the most common treatment adopted.
In our study only four patients (3.3%) had upper urinary tract dilatation. The incidence in the literature is low in multiple sclerosis patients compared to the spinal cord injury patient population. Blaivas and Barbalias 17 identi®ed certain risk factors referable to voiding dysfunction in patients with multiple sclerosis. These include an indwelling catheter, detrusor striated sphincter dyssynergia in men and decreased compliance, resulting in sustained intravesical pressures greater than 40 cm of water.
We found that multiple sclerosis patients who are clinically stable after an initial complete evaluation usually do not require annual evaluation of the upper tract.
Conclusions
Namerow and Thompson 18 described the current state of knowledge succinctly when they said:`One should be clear in dierentiating the disease process per se from the causes of symptoms, since the two may at times be quite independent'.
Urologists should realize that each patient with multiple sclerosis can suer from lower urinary tract disorders, not necessarily related to the duration of the disease or to the disability status. The goal of management of these patients is to preserve renal function, and to control their most bothersome urinary symptoms. Urodynamic abnormalities appear to be related to disease duration and disability status, thus we think that early treatment based upon objective criteria, urodynamic evaluation and closer follow-up can reduce morbidity and improve quality of life.
